Literature DB >> 8569431

Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes.

R Matsushima-Nishiwaki1, Y Shidoji, S Nishiwaki, T Yamada, H Moriwaki, Y Muto.   

Abstract

Microcystin-LR is a liver tumor promoter in the okadaic acid class, a group of potent inhibitors of protein phosphatases 1 and 2A. Because of inhibition of protein phosphatases, microcystin-LR induces hyperphosphorylation of cellular proteins, including cytoskeletal proteins--cytokeratins 8 and 18--and causes morphological changes in mouse hepatocytes in primary culture. We studied the effects of carotenoids to antagonize microcystin-LR-induced morphological changes in hepatocytes. beta-carotene (100 nM to 100 microns) suppressed the morphological changes induced by 100 nM microcystin-LR in a dose-dependent manner. Other carotenoids tested exerted similar suppressive effects, although retinoids, such as all-trans retinol, all-trans retinoic acid, and 9-cis retinoic acid, were only weakly suppressive. The relative potency of the suppression correlated significantly with the number of conjugated double bonds in the trans configuration. beta-carotene strongly suppressed the hyperphosphorylation of cellular proteins induced by microcystin-LR without significant changes in the basal phosphorylation level. Other antioxidants, such as alpha-tocopherol, did not protect the cells against microcystin-LR. Taken together, the antagonistic effects of carotenoids against microcystin-LR are difficult to explain by their antioxidant or provitamin A activities. Suppression of the hyperphosphorylation of cellular proteins may be a novel mechanism by which carotenoids inhibit tumor promotion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569431     DOI: 10.1007/bf02536288

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  35 in total

1.  Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumor promoter, in primary cultured rat hepatocytes.

Authors:  T Ohta; R Nishiwaki; J Yatsunami; A Komori; M Suganuma; H Fujiki
Journal:  Carcinogenesis       Date:  1992-12       Impact factor: 4.944

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 3.  Tumor promotion by inhibitors of protein phosphatases 1 and 2A: the okadaic acid class of compounds.

Authors:  H Fujiki; M Suganuma
Journal:  Adv Cancer Res       Date:  1993       Impact factor: 6.242

4.  The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group.

Authors: 
Journal:  Ann Epidemiol       Date:  1994-01       Impact factor: 3.797

5.  Retinoic acid and beta-carotene inhibit fibronectin synthesis and release by fibroblasts; antagonism to phorbol ester.

Authors:  G Scita; G Wolf
Journal:  Carcinogenesis       Date:  1994-05       Impact factor: 4.944

6.  Beta-carotene and cancer prevention: the Basel Study.

Authors:  H B Stähelin; K F Gey; M Eichholzer; E Lüdin
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

7.  Beta-carotene and/or vitamin E as modulators of alkylating agents in SCC-25 human squamous carcinoma cells.

Authors:  J L Schwartz; J Tanaka; V Khandekar; T S Herman; B A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

8.  Effect of beta-carotene and wheat bran fiber on colonic aberrant crypt and tumor formation in rats exposed to azoxymethane and high dietary fat.

Authors:  O Alabaster; Z Tang; A Frost; N Shivapurkar
Journal:  Carcinogenesis       Date:  1995-01       Impact factor: 4.944

9.  Hyperphosphorylation of cytokeratins by okadaic acid class tumor promoters in primary human keratinocytes.

Authors:  J Yatsunami; A Komori; T Ohta; M Suganuma; S H Yuspa; H Fujiki
Journal:  Cancer Res       Date:  1993-03-01       Impact factor: 12.701

10.  Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver.

Authors:  T Ohta; E Sueoka; N Iida; A Komori; M Suganuma; R Nishiwaki; M Tatematsu; S J Kim; W W Carmichael; H Fujiki
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

View more
  7 in total

Review 1.  Tomato lycopene and its role in human health and chronic diseases.

Authors:  S Agarwal; A V Rao
Journal:  CMAJ       Date:  2000-09-19       Impact factor: 8.262

2.  Opportunities for prevention of prostate cancer: genetics, chemoprevention, and dietary intervention.

Authors:  Eric A Klein
Journal:  Rev Urol       Date:  2002

Review 3.  Multitargeted therapy of cancer by lycopene.

Authors:  Richard B van Breemen; Natasa Pajkovic
Journal:  Cancer Lett       Date:  2008-06-27       Impact factor: 8.679

Review 4.  Lycopene: Is it Beneficial to Human Health as an Antioxidant?

Authors:  Merve Bacanli; Nurşen Başaran; A Ahmet Başaran
Journal:  Turk J Pharm Sci       Date:  2017-11-20

5.  Retinoid and carotenoid status in serum and liver among patients at high-risk for liver cancer.

Authors:  Yachana Kataria; Ryan J Deaton; Erika Enk; Ming Jin; Milita Petrauskaite; Linlin Dong; Joseph R Goldenberg; Scott J Cotler; Donald M Jensen; Richard B van Breemen; Peter H Gann
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

Review 6.  Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention.

Authors:  Blanche C Ip; Xiang-Dong Wang
Journal:  Nutrients       Date:  2013-12-27       Impact factor: 5.717

7.  Microcystins in water and in microalgae: Do microcystins as microalgae contaminants warrant the current public alarm?

Authors:  Stefano Scoglio
Journal:  Toxicol Rep       Date:  2018-08-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.